Literature DB >> 15866964

Surgical treatment of pigmented villonodular synovitis of the hip.

Laurent Vastel1, Patrick Lambert, Gonzague De Pinieux, Olivier Charrois, Marcel Kerboull, Jean-Pierre Courpied.   

Abstract

BACKGROUND: Pigmented villonodular synovitis of the hip is a rare disease. Synovectomy is generally accepted as the only surgical treatment for the disorder, but there have been few studies with a sufficient sample size and duration of follow-up to allow the evaluation of long-term outcomes. The aim of this study was to determine the long-term outcome of the treatment in sixteen patients.
METHODS: Sixteen patients (nine men and seven women), with a mean age of 35.5 years at the time of surgery, were treated between 1970 and 1996. Complete synovectomy was performed in all patients; in addition, three had a cup arthroplasty, four had a total hip arthroplasty, and one had a monopolar arthroplasty. Clinical and radiographic outcomes were evaluated retrospectively at a mean of 16.7 years postoperatively. Only one patient was followed for less than eight years.
RESULTS: Nine patients needed repeat surgery, but only one had recurrent synovitis, as detected with pathological examination fourteen years after treatment with synovectomy and cup arthroplasty. Secondary osteoarthritis developed in all eight patients who had been treated with synovectomy alone, and four of them required a total hip arthroplasty within the follow-up period.
CONCLUSIONS: These results support earlier data indicating that osteoarthritis consistently develops in patients with pigmented villonodular synovitis of the hip. Complete synovectomy seems to be effective in preventing recurrence of the synovitis, but it does not appear to prevent the development of secondary osteoarthritis.

Entities:  

Mesh:

Year:  2005        PMID: 15866964     DOI: 10.2106/JBJS.C.01297

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  26 in total

1.  [Arthroscopic treatment of an intra-articular tumor of the hip joint].

Authors:  C Mella; J Lara; D Parodi; L Moya; A Nuñez
Journal:  Orthopade       Date:  2010-05       Impact factor: 1.087

Review 2.  [Synovial disorders and loose bodies in the hip joint. Arthroscopic diagnostics and treatment].

Authors:  S Gödde; M Kusma; M Dienst
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

3.  Pigmented villonodular synovitis managed by total synovectomy and cementless total hip arthroplasty.

Authors:  Mohamed Mansour Elzohairy
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-04-26

4.  Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients.

Authors:  Lizz van der Heijden; Sheila R Piner; Michiel Adrianus Josephus van de Sande
Journal:  Int Orthop       Date:  2016-05-12       Impact factor: 3.075

5.  Pigmented villonodular synovitis responsive to imatinib therapy.

Authors:  Wynne M Snoots; David Watkins; Dee Dockery; Robert Mennel; Brennen Scott Cheek
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-04

6.  [Arthroscopic synovectomy of the hip joint].

Authors:  M Wünsch; O Rühmann; W Lipka; D A Stark; S Lerch
Journal:  Oper Orthop Traumatol       Date:  2014-10       Impact factor: 1.154

7.  [Caution in the face of medical invoice recommendations : Violation of competition law by specialist medical professional organizations and societies].

Authors:  L Kuball; A Wienke
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

8.  Surgical dislocation of the hip for excision of benign tumours.

Authors:  Aamer Nisar; Sudhesh Gulhane; Ashish Mahendra; Robert Marshall Dominic Meek; Sanjeev Patil
Journal:  J Orthop       Date:  2014-01-24

9.  Pigmented Villonodular Synovitis of the Knee Joint: A Case Report.

Authors:  Chirag Kapoor; Maulik Jhaveri; Rishit Soni; Malkesh Shah; Parth Rathi; Paresh Golwala
Journal:  Cureus       Date:  2016-10-04

10.  [Bone transplantation with total hip endoprosthesis for diffuse pigmented villonodular synovitis].

Authors:  C Friesecke; R Granes; N Siemssen
Journal:  Orthopade       Date:  2013-10       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.